Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Medicine, Cardiology, Health Technology Assessment +13

Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents

Gregg W. Stone, Jeffrey W. Moses, Stephen G. Ellis et al. · New England Journal of Medicine · 2007 · 1.6K citations · Full text

Medicine, Cardiology, Internal Medicine +15

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Gregg W. Stone, Ali A. Rizvi, William Newman et al. · New England Journal of Medicine · 2010 · 896 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

Elvin Kedhi, Kaiyum Sheik Joesoef, Eugène McFadden et al. · The Lancet · 2010 · 687 citations

Medicine, Cardiology, Interventional Cardiology +9

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

Michael Joner, Gaku Nakazawa, Aloke V. Finn et al. · Journal of the American College of Cardiology · 2008 · 640 citations

Medicine, Biomedical Engineering, Cardiology +10